Form 10-Q - Quarterly report [Sections 13 or 15(d)]

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Upstream Bio (NASDAQ:UPB)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Upstream Bio Charts.

Upstream Bio (NASDAQ:UPB)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Upstream Bio Charts.

Upstream Bio Inc News

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 7 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 18 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 18 December 2024 (1 month ago) • Edgar (US Regulatory)

Upstream Bio Appoints Allison Ambrose as General Counsel
Wednesday 18 December 2024 (1 month ago) • GlobeNewswire Inc.

Upstream Bio Announces Addition to Russell 2000® Index
Tuesday 17 December 2024 (1 month ago) • GlobeNewswire Inc.

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference
Friday 22 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Thursday 7 November 2024 (3 months ago) • GlobeNewswire Inc.

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Wednesday 23 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 16 October 2024 (4 months ago) • Edgar (US Regulatory)

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Wednesday 16 October 2024 (4 months ago) • GlobeNewswire Inc.

More Upstream Bio Inc News Articles

Vontobel Financial Produ...

Societe Generale Effekten

Vontobel Financial Produ...

Vontobel Financial Produ...

Vontobel Financial Produ...

Vontobel Financial Produ...

SSgA SPDR ETFs Europe I ...

International Bank for R...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions